Miscarriage patients have fewer treatment options in states with abortion bans, study shows

A study in the Journal of the American Medical Association found that patients experiencing miscarriage in states with abortion bans have fewer treatment options, including a shift away from the two-drug regimen of mifepristone and misoprostol toward less effective misoprostol-only treatments and increased expectant management. The study highlights risks like higher chances of hemorrhage and infection due to these changes.